Did you know that your version of Internet Explorer is out of date?
To get the best possible experience using our website we recommend downloading one of the below web browsers.

Internet Explorer 9, Firefox, Chrome, or Safari.

Treatment Access News

Health Canada has issued a NOC for Truvada as PrEP

march 1, 2016

Health Canada has issued a Notice of Compliance for once-daily oral Truvada® (emtricitabine 200mg/tenofovir disoproxil fumarate 300mg) in combination  with safer sex practices to reduce the risk of sexually acquired HIV-1 infection in adults at high risk, a strategy known as Pre-Exposure Prophylaxis (PrEP).

This is a critical milestone in the evolution of HIV/AIDS healthcare!

Read the full release